LRRK2 and Parkinson disease: Recent findings indicate that urinary BMP levels are altered in LRRK2 mutation carriers with Parkinson’s disease compared to asymptomatic mutation carriers46–48, supporting the view that altered urinary BMP levels might be reflective of brain pathology.